Skip to content
ppharmaranks
Menu

Best treatments for urinary bladder diseases

3 products may treat urinary bladder diseases, spanning FDA drug classes such as cholinesterase inhibitor, cholinergic muscarinic antagonist. The current highest-rated option is neostigmine methylsulfate. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 3 drugs we list for urinary bladder diseases, 2 are available as lower-cost generics, spanning classes such as cholinesterase inhibitor, cholinergic muscarinic antagonist. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for urinary bladder diseases — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate
Treatments we list for urinary bladder diseases
#DrugRatingPharmacy pays
170/100View →
2Not yet rated$7View →
3Not yet rated$7View →

Full ranking · 3 treatments

Frequently asked

What treats urinary bladder diseases?
Our catalog lists 3 products that may treat urinary bladder diseases, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is neostigmine methylsulfate.
What is the best-rated treatment for urinary bladder diseases?
By our independent recall-safety rating — not an efficacy measure — neostigmine methylsulfate ranks highest among the products we list for urinary bladder diseases. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat urinary bladder diseases?
Treatments for urinary bladder diseases span FDA drug classes including cholinesterase inhibitor, cholinergic muscarinic antagonist. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.